According to the United States Renal Data System (USRDS),<unk>  nephropathy accounts for more than one-third of patients on hemodialysis and the annual mortality rate for patients on hemodialysis is 23.3%. Haemodialysis is recommended for patients who progress to end-stage<unk><unk>  (ESKD) and<unk>  nephropathy is the second most common cause of ESKD after diabetes. Patient prognosis is dependent on numerous factors including age, ethnicity, blood pressure and glomerular filtration rate. Changes in lifestyle factors, such as reduced salt intake and increased physical activity have been shown to improve outcomes but are insufficient without pharmacological treatment.
Hypertensive kidney disease
Renovascular hypertension
Diabetic nephropathy
Lupus nephritis
Benign nephrosclerosis
Polycystic kidney disease
Analgesic nephropathy
Cystic kidney disease